{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:50:41Z","timestamp":1791323441109,"version":"4.3.1"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.humpath.2026.106218","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T06:45:58Z","timestamp":1786171558000},"page":"106218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Myeloid sarcoma: Clinical, pathologic, and molecular findings"],"prefix":"10.1016","author":[{"given":"Ann-Kathrin","family":"Eisfeld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2026.106218_bib1","first-page":"97","article-title":"A case of chloroma","volume":"7","author":"King","year":"1853","journal-title":"Monthly J Med"},{"issue":"64","key":"10.1016\/j.humpath.2026.106218_bib2","first-page":"115","article-title":"A new case of chloroma with leukemia","volume":"19","author":"Dock","year":"1904","journal-title":"Trans Assoc Am Phys"},{"key":"10.1016\/j.humpath.2026.106218_bib3","series-title":"Atlas of tumor pathology, section III, fascicle 8","first-page":"241","article-title":"Tumors of the hematopoietic system","author":"Rappaport","year":"1967"},{"issue":"9","key":"10.1016\/j.humpath.2026.106218_bib4","first-page":"790","article-title":"Extramedullary myeloid cell tumors. An immunohistochemical study of 29 cases using routinely fixed and processed paraffin-embedded tissue sections","volume":"119","author":"Roth","year":"1995","journal-title":"Arch Pathol Lab Med"},{"issue":"5","key":"10.1016\/j.humpath.2026.106218_bib5","article-title":"Myeloid sarcoma, chloroma, or extramedullary acute myeloid leukemia tumor: a tale of misnomers, controversy and the unresolved","volume":"47","author":"Shallis","year":"2021","journal-title":"Blood Rev"},{"key":"10.1016\/j.humpath.2026.106218_bib6","series-title":"Haematolymphoid tumors","first-page":"165","article-title":"Myeloid sarcoma WHO Classification of Tumours","author":"Chen","year":"2024"},{"issue":"2","key":"10.1016\/j.humpath.2026.106218_bib7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3324\/haematol.2012.073189","article-title":"Extramedullary relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcomes","volume":"98","author":"Harris","year":"2013","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.humpath.2026.106218_bib8","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1038\/s41590-026-02582-8","article-title":"Inflammatory immune modulators of AML lung infiltration and respiratory failure","volume":"27","author":"Paraskevopoulou","year":"2026","journal-title":"Nat Immunol"},{"issue":"14","key":"10.1016\/j.humpath.2026.106218_bib9","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1182\/blood-2011-04-347229","article-title":"How I treat extramedullary acute myeloid leukemia","volume":"118","author":"Bakst","year":"2011","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.humpath.2026.106218_bib10","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/PAS.0000000000001689","article-title":"Clinicopathologic features of myelodysplastic syndromes involving lymph nodes","volume":"45","author":"Fang","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.humpath.2026.106218_bib11","doi-asserted-by":"crossref","first-page":"4988","DOI":"10.21037\/tcr-19-2882","article-title":"Leukaemia cutis as a specific skin involvement in chronic myelomonocytic leukaemia and review of the literature","volume":"9","author":"Qiao","year":"2020","journal-title":"Transl Cancer Res"},{"issue":"6","key":"10.1016\/j.humpath.2026.106218_bib12","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/ajh.27271","article-title":"Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management","volume":"99","author":"Patnaik","year":"2024","journal-title":"Am J Hematol"},{"issue":"10","key":"10.1016\/j.humpath.2026.106218_bib13","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/ijd.16809","article-title":"Cutaneous involvement in Ph-negative myeloproliferative neoplasms: from extramedullary hematopoiesis to myeloid metastasis with histiocytic differentiation. A systematic review of the literature","volume":"62","author":"Bonometti","year":"2023","journal-title":"Int J Dermatol"},{"issue":"6","key":"10.1016\/j.humpath.2026.106218_bib14","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.3324\/haematol.2019.223032","article-title":"The prevalence of extramedullary acute myeloid leukemia detected by 18FDG-PET\/CT: final results from the prospective PETAML trial","volume":"105","author":"St\u00f6lzel","year":"2020","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.humpath.2026.106218_bib15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/ejh.12085","article-title":"Extramedullary disease in patients with acute myeloid leukemia assessed by 18F-FDG PET","volume":"90","author":"Cribe","year":"2013","journal-title":"Eur J Haematol"},{"issue":"4","key":"10.1016\/j.humpath.2026.106218_bib16","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/1097-0142(197304)31:4<948::AID-CNCR2820310428>3.0.CO;2-N","article-title":"Autopsy study of granulocytic sarcoma (chloroma) in patients with myelogenous leukemia, Hiroshima-Nagasaki 1949-1969","volume":"31","author":"Liu","year":"1973","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.humpath.2026.106218_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2017.79","article-title":"Clinical features and outcomes of extramedullary myeloid sarcoma in the United States: analysis using a national data set","volume":"7","author":"Goyal","year":"2017","journal-title":"Blood Cancer J"},{"issue":"29","key":"10.1016\/j.humpath.2026.106218_bib18","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1200\/JCO.2016.67.5892","article-title":"Extramedullary disease in adult acute myeloid leukemia is common but lacks independent significance: analysis of patients in ECOG-ACRIN cancer research group trials, 1980-2008","volume":"34","author":"Ganzel","year":"2016","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.humpath.2026.106218_bib19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41409-020-0984-4","article-title":"Extra-medullary recurrence of myeloid leukemia as myeloid sarcoma after allogeneic stem cell transplantation: impact of conditioning intensity","volume":"56","author":"Frietsch","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.humpath.2026.106218_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.103170","article-title":"Post-transplant leukemia relapse in organs: biology and behavior in 585 reports","volume":"157","author":"Cunningham","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"issue":"Supplement 1","key":"10.1016\/j.humpath.2026.106218_bib21","doi-asserted-by":"crossref","first-page":"12333","DOI":"10.1182\/blood-2022-163324","article-title":"Myeloid sarcoma in myelodysplastic syndrome: review","volume":"140","author":"Aldapt","year":"2022","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.humpath.2026.106218_bib22","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1309\/AJCPO58YWIBUBESX","article-title":"Extramedullary manifestations of myeloid neoplasms","volume":"144","author":"Wilson","year":"2015","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.humpath.2026.106218_bib23","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1309\/AJCP1ZA7HYZKAZHS","article-title":"Myeloid sarcoma: extramedullary manifestation of myeloid disorders","volume":"132","author":"Campidelli","year":"2009","journal-title":"Am J Clin Pathol"},{"issue":"11","key":"10.1016\/j.humpath.2026.106218_bib24","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1097\/PAS.0000000000000727","article-title":"Clinicopathological, cytogenetic, and prognostic analysis of 131 myeloid sarcoma patients","volume":"40","author":"Kawamoto","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.humpath.2026.106218_bib25","doi-asserted-by":"crossref","first-page":"32","DOI":"10.5858\/2005-129-32-MSITB","article-title":"Myeloid sarcoma involving the breast","volume":"129","author":"Valbuena","year":"2005","journal-title":"Arch Pathol Lab Med"},{"issue":"5","key":"10.1016\/j.humpath.2026.106218_bib26","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1309\/H9MM21FPT7YBL3PW","article-title":"Myeloid sarcoma involving the gynecologic tract: a report of 11 cases and review of the literature","volume":"125","author":"Garcia","year":"2006","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.humpath.2026.106218_bib27","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1309\/NXLCJ1B16YDFQWND","article-title":"Myeloid sarcoma involving the testis","volume":"124","author":"Valbuena","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2026.106218_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2025.156106","article-title":"Myeloid sarcomas of the genitourinary tract: a multi-institutional study of sixteen tumors with review of literature","volume":"272","author":"Shafi","year":"2025","journal-title":"Pathol Res Pract"},{"issue":"1","key":"10.1016\/j.humpath.2026.106218_bib29","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1309\/WYACYWF6NGM3WBRT","volume":"129","author":"Cho-Vega","year":"2008","journal-title":"Leukemia cutis Am J Clin Pathol"},{"issue":"8","key":"10.1016\/j.humpath.2026.106218_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2025.100716","article-title":"Erythroblastic sarcoma in adults and children: different pathways to the same destination","volume":"38","author":"Fitzpatrick","year":"2025","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.humpath.2026.106218_bib31","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.pathol.2021.08.015","article-title":"Clinicopathological analysis of myeloid sarcoma with megakaryocytic differentiation","volume":"54","author":"Nagamine","year":"2022","journal-title":"Pathology"},{"issue":"3","key":"10.1016\/j.humpath.2026.106218_bib32","first-page":"336","article-title":"FAB classification of leukemia: a cytochemical study","volume":"47","author":"Sharma","year":"2004","journal-title":"Indian J Pathol Microbiol"},{"issue":"1","key":"10.1016\/j.humpath.2026.106218_bib33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000526635","article-title":"Myeloid sarcoma: features in cytological preparations and the utility of rapid on-site evaluation (ROSE) in triage","volume":"67","author":"Tariq","year":"2023","journal-title":"Acta Cytol"},{"issue":"1","key":"10.1016\/j.humpath.2026.106218_bib34","doi-asserted-by":"crossref","DOI":"10.1093\/labmed\/lmaf089","article-title":"Unveiling the hidden: diagnosing isolated myeloid sarcoma through ascitic fluid analysis","volume":"57","author":"Zhou","year":"2026","journal-title":"Lab Med"},{"issue":"2","key":"10.1016\/j.humpath.2026.106218_bib35","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/sj.leu.2404491","article-title":"Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients","volume":"21","author":"Pileri","year":"2007","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.humpath.2026.106218_bib36","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1046\/j.1365-2559.1999.00651.x","article-title":"Extra-medullary myeloid tumour (granulocytic sarcoma) is often misdiagnosed: a study of 26 cases","volume":"34","author":"Menasce","year":"1999","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2026.106218_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2022.03.001","article-title":"Myeloid sarcoma and extramedullary hematopoiesis expand the spectrum of ERG-positive proliferations: an ancillary tool in the diagnosis","volume":"124","author":"Vargas","year":"2022","journal-title":"Hum Pathol"},{"issue":"9","key":"10.1016\/j.humpath.2026.106218_bib38","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.3324\/haematol.2021.280487","article-title":"Pure erythroid leukemia is characterized by biallelic TP53 inactivation and abnormal p53 expression patterns in de novo and secondary cases","volume":"107","author":"Fang","year":"2022","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.humpath.2026.106218_bib39","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/his.13864","article-title":"Clinicopathological and molecular characteristics of extramedullary acute myeloid leukaemia","volume":"75","author":"Ullman","year":"2019","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.humpath.2026.106218_bib40","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/08880018.2020.1803462","article-title":"Characteristics and prognosis of pediatric myeloid sarcoma in the cytogenetic context of t(8;21)","volume":"38","author":"Hu","year":"2021","journal-title":"Pediatr Hematol Oncol"},{"issue":"3","key":"10.1016\/j.humpath.2026.106218_bib41","first-page":"333","article-title":"Myeloid sarcoma with CBFB-MYH11 fusion (inv(16) or t(16;16)) prevails in the abdomen","volume":"153","author":"Dalland","year":"2020","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"10.1016\/j.humpath.2026.106218_bib42","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.leu.2404006","article-title":"Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy","volume":"20","author":"de Botton","year":"2006","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.humpath.2026.106218_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/2056-4538.70079","article-title":"Frequent NPM1 mutation, monoblastic\/monocytic origin and prognostic significance of organ and system involvement in myeloid sarcoma: a multicenter study","volume":"12","author":"Jenei","year":"2026","journal-title":"J Pathol Clin Res"},{"key":"10.1016\/j.humpath.2026.106218_bib44","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2026.300540","article-title":"Disease course of FLT3 mutated extramedullary acute myeloid leukemia and efficacy of gilteritinib","author":"Angotzi","year":"2026","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.humpath.2026.106218_bib45","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.1038\/s41598-022-10831-7","article-title":"Clinical characteristics, treatment, and prognosis of 118 cases of myeloid sarcoma","volume":"12","author":"Zhao","year":"2022","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.humpath.2026.106218_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/2056-4538.70044","article-title":"Myeloid sarcoma shows a high frequency of mutations activating the MAPK\/ERK pathway and association with clonal hematopoiesis","volume":"11","author":"Nann","year":"2025","journal-title":"J Pathol Clin Res"},{"issue":"1","key":"10.1016\/j.humpath.2026.106218_bib47","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41408-025-01345-2","article-title":"Genomic and immunogenomic profiling of extramedullary acute myeloid leukemia reveals actionable clonal branching and frequent immune editing","volume":"15","author":"Collignon","year":"2025","journal-title":"Blood Cancer J"},{"issue":"1","key":"10.1016\/j.humpath.2026.106218_bib48","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1182\/blood.2025029121","article-title":"Mechanisms of immune escape and extramedullary tropism in leukemia cutis","volume":"147","author":"Penter","year":"2026","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2026.106218_bib49","doi-asserted-by":"crossref","unstructured":"Nadorp B., Lasry A., Loghavi S., Patel R., Mansour H., Rovatti PE., Kelly BJ., Walker CJ., Buss J., Boateng I., Al-Santli W., Ciantra Z., Austin R., Desai H., Abaza H., Procell L., Patel T., Kaffenberger B., Wijeratne S., Guillamot M., Velegraki M., Chiriboga LA., Li Z., Pollyea DA., McMahon CM., Shanaah A., Byrd JC., Esteller M., Papapetrou EP,. Tsirigos A., Mims AS., Mardis ER., Aifantis I., Eisfeld AK. RAS pathway activation and microenvironmental adaptation as hallmarks of myeloid sarcoma. Blood Cancer Discov 7, 5, 759-773. 10.1158\/2643-3230.BCD-26-0160.","DOI":"10.1158\/2643-3230.BCD-26-0160"},{"issue":"3","key":"10.1016\/j.humpath.2026.106218_bib50","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jmoldx.2019.11.004","article-title":"Molecular discordance between myeloid sarcomas and concurrent bone marrows occurs in actionable genes and is associated with worse overall survival","volume":"22","author":"Werstein","year":"2020","journal-title":"J Mol Diagn"},{"issue":"7","key":"10.1016\/j.humpath.2026.106218_bib51","first-page":"762","article-title":"Drugging the 'undruggable' KRAS: breakthroughs, challenges, and opportunities in pancreatic cancer","volume":"22","author":"Khan","year":"2025","journal-title":"Cancer Biol Med"},{"issue":"11","key":"10.1016\/j.humpath.2026.106218_bib52","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nrc3106","article-title":"RAS oncogenes: weaving a tumorigenic web","volume":"11","author":"Pylayeva-Gupta","year":"2011","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"10.1016\/j.humpath.2026.106218_bib53","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00262-024-03926-9","article-title":"Effect of RAS mutations and related immune characteristics on the prognosis of patients with MSI-H\/dMMR colorectal cancer","volume":"74","author":"Jiang","year":"2025","journal-title":"Cancer Immunol Immunother"},{"issue":"5","key":"10.1016\/j.humpath.2026.106218_bib54","first-page":"869","article-title":"Differential expression of adhesion molecules in acute leukemia","volume":"9","author":"Reuss-Borst","year":"1995","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.humpath.2026.106218_bib55","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/pbc.22500","article-title":"Chemokine\/chemokine receptor interactions in extramedullary leukaemia of the skin in childhood AML: differential roles for CCR2, CCR5, CXCR4 and CXCR7","volume":"55","author":"Faaij","year":"2010","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"10.1016\/j.humpath.2026.106218_bib56","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.bbmt.2019.01.011","article-title":"Extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation","volume":"25","author":"Yuda","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"10.1016\/j.humpath.2026.106218_bib57","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1038\/leu.2012.156","article-title":"Allogeneic hematopoietic stem cell transplantation for adult AML patients with granulocytic sarcoma","volume":"26","author":"Shimizu","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2026.106218_bib58","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.bbmt.2012.05.010","article-title":"Extramedullary relapse of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: an easily overlooked but significant pattern of relapse","volume":"18","author":"Yoshihara","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.humpath.2026.106218_bib59","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.3390\/cancers17243975","article-title":"Clinical and molecular characterization of myeloid sarcoma: a systematic review and meta-analysis","volume":"17","author":"Padmanabhan","year":"2025","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.humpath.2026.106218_bib60","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1038\/s41375-024-02337-0","article-title":"Clinical and molecular characteristics of extramedullary acute myeloid leukemias","volume":"38","author":"Kewan","year":"2024","journal-title":"Leukemia"},{"issue":"21","key":"10.1016\/j.humpath.2026.106218_bib61","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1182\/blood.V116.21.4558.4558","article-title":"Allogeneic stem cell transplantation (allo-SCT) for isolated and leukemic myeloid sarcoma (GS): a survey on behalf of the acute leukemia working party (ALWP) of EBMT","volume":"116","author":"Chevallier","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.humpath.2026.106218_bib62","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/hon.994","article-title":"Clinical implications of acute myeloid leukemia presenting as granulocytic sarcoma","volume":"30","author":"Avni","year":"2012","journal-title":"Hematol Oncol"},{"issue":"1","key":"10.1016\/j.humpath.2026.106218_bib63","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s12672-024-01068-z","article-title":"Real-world experience with venetoclax-based therapy for patients with myeloid sarcoma","volume":"15","author":"Jian","year":"2024","journal-title":"Discov Oncol"},{"issue":"2","key":"10.1016\/j.humpath.2026.106218_bib64","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3324\/haematol.2024.285985","article-title":"Outcome of adult acute myeloid leukemia patients with extramedullary disease and treatment with venetoclax\/hypomethylating agents","volume":"110","author":"Kayser","year":"2025","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2026.106218_bib65","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/cncr.23691","article-title":"Myeloid sarcoma is associated with superior event-free survival compared with acute myeloid leukemia","volume":"113","author":"Tsimberidou","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2026.106218_bib66","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1002\/cncr.34459","article-title":"Molecular annotation of extramedullary acute myeloid leukemia identifies high prevalence of targetable mutations","volume":"128","author":"Ball","year":"2022","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.humpath.2026.106218_bib67","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1182\/blood.2025028357","article-title":"Menin inhibition with revumenib for NPM1-mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study","volume":"146","author":"Arellano","year":"2025","journal-title":"Blood"},{"issue":"7954","key":"10.1016\/j.humpath.2026.106218_bib68","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/s41586-023-05812-3","article-title":"The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia","volume":"615","author":"Issa","year":"2023","journal-title":"Nature"},{"issue":"Suppl 1","key":"10.1016\/j.humpath.2026.106218_bib69","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1182\/blood-2025-1727","article-title":"Radiotherapy of extramedullary acute myeloid leukemias overcomes resistance to checkpoint blockade that is enhanced by natural killer cell depletion","volume":"146","author":"Saenz","year":"2025","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.humpath.2026.106218_bib70","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.3390\/cancers17081354","article-title":"Association between B-cell marker expression and RUNX1 lesions in acute myeloid leukemia, beyond RUNX1::RUNX1T1 fusion: diagnostic pitfalls with mixed-phenotype acute leukemia-B\/myeloid","volume":"17","author":"George","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.humpath.2026.106218_bib71","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1309\/LG0Q0VXYBETJ4VHE","article-title":"Expression of B cell-specific activator protein\/PAX5 in acute myeloid leukemia with t(8;21)(q22;q22)","volume":"126","author":"Valbuena","year":"2006","journal-title":"Am J Clin Pathol"},{"issue":"2\u20133","key":"10.1016\/j.humpath.2026.106218_bib72","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000493688","article-title":"RUNX1 mutations can lead to aberrant expression of CD79a and PAX5 in acute myelogenous leukemias: a potential diagnostic pitfall","volume":"86","author":"Menter","year":"2019","journal-title":"Pathobiology"},{"issue":"4","key":"10.1016\/j.humpath.2026.106218_bib73","doi-asserted-by":"crossref","DOI":"10.1002\/jha2.70089","article-title":"Aggressive myeloid sarcoma mimicking Burkitt's lymphoma","volume":"6","author":"Hassan","year":"2025","journal-title":"EJHaem"},{"key":"10.1016\/j.humpath.2026.106218_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2024.105703","article-title":"Burkitt lymphoma","volume":"156","author":"Fang","year":"2025","journal-title":"Hum Pathol"},{"issue":"5","key":"10.1016\/j.humpath.2026.106218_bib75","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1309\/R2Q9CCUVTLRYCF3H","article-title":"Anaplastic large cell lymphoma","volume":"127","author":"Medeiros","year":"2007","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.humpath.2026.106218_bib76","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.critrevonc.2010.12.003","article-title":"Lymphoblastic lymphoma","volume":"79","author":"Cortelazzo","year":"2011","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"10.1016\/j.humpath.2026.106218_bib77","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1309\/AJCPMF03LVSBLHPJ","article-title":"T-lymphoblastic leukemia\/lymphoma","volume":"144","author":"You","year":"2015","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"10.1016\/j.humpath.2026.106218_bib78","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/ajcp\/aqad022","article-title":"B-cell lineage neoplasms transdifferentiating into histiocytic\/dendritic cell neoplasms: diversity, differentiation lineage, genomic alterations, and therapy: report from the 2021 SH\/EAHP workshop","volume":"159","author":"Xiao","year":"2023","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"10.1016\/j.humpath.2026.106218_bib79","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/s41379-018-0200-x","article-title":"Identification of diverse activating mutations of the RAS-MAPK pathway in histiocytic sarcoma","volume":"32","author":"Shanmugam","year":"2019","journal-title":"Mod Pathol"},{"issue":"9","key":"10.1016\/j.humpath.2026.106218_bib80","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1002\/cncr.10489","article-title":"CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia","volume":"94","author":"Khoury","year":"2002","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.humpath.2026.106218_bib81","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1097\/PAS.0000000000001316","article-title":"Dual expression of TCF4 and CD123 is highly sensitive and specific for blastic plasmacytoid dendritic cell neoplasm","volume":"43","author":"Sukswai","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.humpath.2026.106218_bib82","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/cup.14439","article-title":"IRF8 may be a useful marker for blastic plasmacytoid dendritic cell neoplasm, especially with weak CD123 expression","volume":"50","author":"Tang","year":"2023","journal-title":"J Cutan Pathol"},{"issue":"8","key":"10.1016\/j.humpath.2026.106218_bib83","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/modpathol.2013.238","article-title":"Optimized immunohistochemical panel to differentiate myeloid sarcoma from blastic plasmacytoid dendritic cell neoplasm","volume":"27","author":"Sangle","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2026.106218_bib84","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/bs.ircmb.2021.07.002","article-title":"Extramedullary hematopoiesis in myeloproliferative neoplasms: pathophysiology and treatment strategies","volume":"365","author":"Chernak","year":"2021","journal-title":"Int Rev Cell Mol Biol"},{"issue":"4","key":"10.1016\/j.humpath.2026.106218_bib85","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/modpathol.3800768","article-title":"Benign extramedullary myeloid proliferations","volume":"20","author":"O'Malley","year":"2007","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.humpath.2026.106218_bib86","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00000478-200001000-00006","article-title":"Sclerosing extramedullary hematopoietic tumor in chronic myeloproliferative disorders","volume":"24","author":"Remstein","year":"2000","journal-title":"Am J Surg Pathol"},{"issue":"Suppl 5","key":"10.1016\/j.humpath.2026.106218_bib87","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1016\/j.htct.2023.07.005","article-title":"Extramedullary haematopoiesis in patients with thalassemia: a cross-sectional description of its prevalence, clinical features and survival","volume":"46","author":"Chapchap","year":"2024","journal-title":"Hematol Transfus Cell Ther"},{"issue":"3","key":"10.1016\/j.humpath.2026.106218_bib88","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/ajcp\/aqae131","article-title":"Myeloid sarcomas with CBFA2T3 : GLIS2 fusion: clinicopathologic characterization of 4 cases mimicking small round cell tumors","volume":"163","author":"Malik","year":"2025","journal-title":"Am J Clin Pathol"},{"issue":"12","key":"10.1016\/j.humpath.2026.106218_bib89","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.3390\/ijms26125895","article-title":"Extramedullary relapse of CBFA2T3::GLIS2-positive megakaryoblastic leukemia mimicking secondary ewing sarcoma: an exemplary case for the diagnostic trap","volume":"26","author":"Lebedeva","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.humpath.2026.106218_bib90","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.pathol.2022.12.353","article-title":"Myeloid sarcoma: a poorly recognised but important differential diagnosis of epithelioid angiosarcoma","volume":"55","author":"Wong","year":"2023","journal-title":"Pathology"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726001875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726001875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:06:45Z","timestamp":1791320805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817726001875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":90,"alternative-id":["S0046817726001875"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106218","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myeloid sarcoma: Clinical, pathologic, and molecular findings","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106218","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106218"}}